Status:
TERMINATED
Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT
Lead Sponsor:
Washington University School of Medicine
Conditions:
Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators propose a longitudinal study evaluating post-treatment changes in patients with squamous cell carcinoma (SCC) of the neck using an innovative optimized diffusion-weighted imaging (DW...
Eligibility Criteria
Inclusion
- Histologically-proven newly diagnosis or recurrence as indicated by tissue diagnosis of T3 or T4 squamous cell carcinoma of the head and neck
- Must have had or be scheduled for standard-of-care surgical resection, radiation, and/or chemo-radiation of the diagnosed squamous cell carcinoma of the head and neck
- At least 18 years of age
- Patient must be able to understand and willing to sign a written informed consent document.
Exclusion
- Contraindications to MRI, including:
- MRI-incompatible implantable devices
- severe claustrophobia; and
- Pregnant and/or breastfeeding, with women of childbearing potential having a negative urine or serum pregnancy test
Key Trial Info
Start Date :
September 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 26 2023
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04685798
Start Date
September 2 2020
End Date
September 26 2023
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110